Most people who try CBD for the first time are trying it for one of two reasons. They want help with anxiety, or they want help with sleep.
What surprises people is what happens next. CBD does not produce a high or create an immediate effect feeling. For many users, it produces something closer to a slow exhale – a quieting of the racing thoughts, a softening of the body, a return to baseline. Not euphoria. Just calm.
That difference matters, and the reason for it is worth understanding.
When people learn about cannabis and the body, they usually learn about cannabinoid receptors (CB1 and CB2) and the endocannabinoid system (ECS) that uses them. But CBD, the compound most associated with the calming effects of cannabis, does not actually bind CB1 receptors strongly. It works on the brain through a different route, which includes a direct interaction with the receptors your body uses for a molecule you have almost certainly heard of: serotonin.
This is the fourth piece in a series on how the endocannabinoid system relates to the other chemical messengers in your body. So far we’ve looked at endorphins (a case of misattribution), oxytocin (a partnership), and dopamine (a regulator). Serotonin is something different again. With serotonin, the connection is more direct than any of the previous three, and it’s the reason a great deal of what we now know about CBD makes sense.
What Serotonin Actually Is
Serotonin, technically called 5-hydroxytryptamine or 5-HT, is one of the most widely studied molecules in human biology. It is involved in mood regulation, sleep, appetite, body temperature, pain perception, sexual function, and digestive motility. When people talk about depression and SSRIs, they are talking about serotonin. When people talk about gut-brain communication, they are talking (in large part) about serotonin.
It is produced from the amino acid tryptophan and operates through at least fourteen different receptor subtypes, organized into seven major families (5-HT1 through 5-HT7). Different serotonin receptors do different jobs. Some are calming. Some are activating. Some are involved in nausea. Some are involved in psychedelic experiences. This receptor diversity is part of why serotonin can influence so many different physiological processes.
There is one fact about serotonin that surprises most people, and it matters here. Roughly 90% of your body’s serotonin is not in your brain. It is in your gut. Specialized cells lining your intestines, called enterochromaffin cells, produce serotonin that regulates digestion, gut motility, and communication between your gut and your nervous system. The “gut feeling” you’ve heard about is, in a meaningful chemical sense, a serotonin phenomenon.
This becomes important later. Because the endocannabinoid system is also heavily present in the gut, and the two systems meet there, in ways that have only recently begun to be mapped.
What Endocannabinoids Actually Are: A short refresher for new readers
Endocannabinoids are lipid-based molecules (fats) produced by your body throughout the central and peripheral nervous systems. The two most studied are anandamide (AEA), named after the Sanskrit word for bliss, and 2-arachidonoylglycerol (2-AG).
They bind to two main receptors, CB1 and CB2, which are distributed widely throughout the brain, immune system, gut, and other tissues. Together with the enzymes that build and break them down, these molecules and receptors form the endocannabinoid system (ECS) one of the body’s most far-reaching regulatory networks, involved in mood, pain, appetite, sleep, immune function, memory, and reward.
The cannabis plant produces compounds called phytocannabinoids, THC, CBD, and others, that interact with this system. But here is where serotonin enters the story.
CBD Binds Serotonin Receptors Directly
Cannabidiol (CBD) is the second most abundant compound in the cannabis plant after THC. It is non-intoxicating. It does not produce the high associated with cannabis. And, despite being a phytocannabinoid, it does not bind tightly to the CB1 receptor (the receptor responsible for most of the psychoactive effects of THC.)
So how does CBD work?
Part of the answer is that CBD has what researchers call a “promiscuous” pharmacology. It interacts with multiple receptor systems, not just one. And one of its most important interactions, particularly for its calming and anti-anxiety effects, is a direct interaction with serotonin receptors, specifically the 5-HT1A receptor.
The 5-HT1A receptor is one of serotonin’s primary calming receptors. When it is activated, it tends to reduce anxiety, lower stress responses, and dampen overactive neural circuits. Antidepressants like buspirone work through this receptor. Many of the mood-stabilizing effects of serotonin in the brain happen through 5-HT1A signaling.
CBD activates this receptor directly. Research published in journals including British Journal of Pharmacology, Neurochemistry International, PAIN, and Frontiers in Behavioral Neuroscience has demonstrated that CBD’s anxiolytic (anxiety-reducing) effects depend substantially on this 5-HT1A interaction. Studies in animal models have shown that blocking 5-HT1A receptors blocks the anti-anxiety effects of CBD. A 2019 study in PAIN found that CBD reduces anxiety in chronic pain conditions primarily through 5-HT1A activation, not through cannabinoid receptors. A 2015 study in Neuropharmacology demonstrated that CBD’s antidepressant-like effects in animal models depend on 5-HT1A signaling.
This is a substantial finding. It means that one of the most therapeutically interesting compounds from cannabis works on the brain through the same receptor family targeted by mainstream antidepressants, not through the recreational cannabis pathway. The calming effect people describe from CBD is, mechanistically, more of a serotonin story than a cannabinoid story.
CBD also interacts with other serotonin receptors, including 5-HT2A, the same receptor activated by psychedelic compounds like LSD and psilocybin. But CBD’s interaction with 5-HT2A is different. It modulates the receptor without producing the dramatic perceptual changes that classical psychedelics do. This is one of several ways in which CBD pharmacology genuinely does not look like anything else in nature.
Where the Two Systems Genuinely Overlap
The CBD-5-HT1A connection is the most striking direct interaction between phytocannabinoids and the serotonin system, but it is not the only point of contact. Research over the past two decades has established what one major 2021 review in the Progress in Neuro-Psychopharmacology & Biological Psychiatry series called “a bidirectional interaction between the endocannabinoid and serotonin systems.”
Both systems regulate mood. Both are implicated in depression and anxiety. Both interact in the dorsal raphe nucleus (the brain region that produces most of the serotonin used in the forebrain) where CB1 receptors and serotonin neurons coexist closely. Activating cannabinoid receptors in this region influences serotonin firing. Modulating serotonin influences endocannabinoid signaling.
Both also play roles in sleep, appetite regulation, and pain modulation. Many of the conditions for which people seek cannabinoid therapies (chronic pain, anxiety, insomnia, depression, PTSD) involve dysregulation in both systems. It is rarely a case of “either the serotonin system or the endocannabinoid system.” It is usually both.
This is part of why the simple narrative of “cannabis activates one receptor system” misses what is actually happening. A whole-plant cannabis product, or a full-spectrum CBD product, is engaging multiple receptor systems at once. The therapeutic effect, when it appears, emerges from the interaction.
The Gut Connection
This is where the story gets even more interesting, and where the serotonin-endocannabinoid relationship has practical implications most readers have not considered.
Ninety percent of the body’s serotonin is in the gut. The endocannabinoid system is also heavily represented in the gut, particularly through CB2 receptors and through anandamide produced by intestinal cells. Both systems are involved in gut motility, inflammation, and the gut-brain communication that influences mood and stress responses.
Emerging research suggests the two systems interact in the gut to regulate everything from digestive function to immune response to the inflammatory signaling that may underlie certain forms of depression. This is part of why interest in cannabinoid therapies for inflammatory bowel conditions, IBS, and gut-brain disorders has grown significantly in recent years. It is also part of why the broader conversation about cannabis and mental health cannot be separated from the conversation about cannabis and gut health.
What About SSRIs?
If you are taking an SSRI or other serotonin-modulating medication, the question of whether CBD or other cannabinoids fit into your care is one to discuss with your prescriber. Here is why: both CBD and many psychiatric medications are processed by the same liver enzymes (the cytochrome P450 system). CBD can change how those enzymes work, which can affect the blood levels of certain medications – sometimes raising them, sometimes lowering them. This is not necessarily a reason to avoid CBD if you are on these medications, but it is a reason to coordinate with your physician.
We are not your doctor or make this decision for you. What we can do is help you have an informed conversation with your physician, share what the research currently shows, and connect you with resources. That is what our care team is for, and it is part of why we exist.
Where the Two Systems Differ
To pull the comparison fully into view:
Chemistry. Serotonin is a monoamine neurotransmitter, built from the amino acid tryptophan. Endocannabinoids are lipids, built from fatty acid precursors. They are entirely different classes of molecules.
Distribution. Roughly 90% of the body’s serotonin is in the gut; the remaining 10% acts centrally in the brain. The endocannabinoid system is distributed throughout both, heavily present in the central nervous system, the immune system, the gut, the skin, and reproductive tissue.
Storage. Serotonin is synthesized and stored in vesicles, ready for release. Endocannabinoids are not stored at all but they are built on demand and broken down quickly.
Receptors. Serotonin has at least 14 receptor subtypes across seven families. The endocannabinoid system has two main receptors (CB1 and CB2), though endocannabinoids also interact with other receptors including TRPV1 and PPAR. The receptor diversity of the serotonin system is part of why it has such a wide range of effects.
Plant interactions. This is where the comparison becomes most distinct. The cannabis plant interacts with both systems but in different ways. THC binds cannabinoid receptors directly. CBD binds serotonin receptors directly. This is unusual. There are few plant compounds in the natural world that bind serotonin receptors with the affinity CBD does, and the fact that the cannabis plant happens to produce both kinds of compounds, one for the endocannabinoid system and one for the serotonin system, is part of what makes it such a multifaceted source of therapeutic candidates.
Finding Help
When Realm of Caring was founded thirteen years ago, the conversation about CBD was dominated by the story of Charlotte Figi, whose seizures responded to CBD in ways that changed how the world thinks about cannabis and medicine. That story remains central to our work. And the science of why CBD does what it does has continued to unfold in the years since.
Part of what researchers have come to understand is that CBD’s effects on the brain are not happening through one simple mechanism. The breadth of its potential is not because CBD is a magic compound, it is because the systems it engages, including serotonin, are themselves involved in a wide range of physiological functions.
This is also why the conversation about cannabinoid therapies cannot be reduced to “it’s all about cannabis receptors.” The endocannabinoid system is one part of a larger network of internal regulatory systems, and cannabinoids interact with that broader network in ways researchers are still mapping. The serotonin connection is one of the clearest illustrations of this, and one of the most clinically relevant.
If you are exploring CBD or other cannabinoid therapies, for any condition, our care team is available worldwide at no cost. Our Research Library holds nearly 4,000 peer-reviewed studies on cannabinoids and human health, including a growing body of work on the CBD-serotonin connection.
Coming Up Next
Future pieces in this series will examine how endocannabinoids interact with GABA (the body’s primary inhibitory neurotransmitter and a key player in anxiety and sleep) along with cortisol and the stress response, and other major chemical messengers. Each comparison reveals a different facet of the same underlying network of internal chemistry that keeps you balanced, regulated, and well.
